Publications

At Ichnos Sciences, we’re working to make real progress in science and medicine. Explore our recent publications to discover how we’re shifting medicine forward. 

Date Title Lead Author Journal
06/28/2022 Optimization of a Cell Culture Clarification Platform Process With the Aim of Boosting the Recovery of Bispecific Antibodies (PDF) Mette R. et al. Presentation at ESACT2022 Conference
06/28/2022 Increased Throughput in Upstream Development via Automated Feed Strategy Using Qubicon® (PDF) Schmid S. et al. Presentation at ESACT2022 Conference
06/27/2022 Assessment Of The Impact Of The Milling Type And Production Site For Cell Culture Feed Production (PDF) Le Moal M. et al. Presentation at ESACT2022 Conference
06/10/2022 ISB 1442 ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of CD38+ Malignancies (PDF) Sammicheli S. et al. Presentation during EHA2022
04/13/2022 ISB 1442 ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of CD38+ Malignancies (PDF) Sammicheli S. et al. American Association for Cancer Research Annual Meeting
11/04/2021 ISB 1442 ISB 1442, a First-in-Class CD38 and CD47 Bispecific Antibody Innate Cell Modulator for the Treatment of Relapsed Refractory Multiple Myeloma Sammicheli S. et al. American Society of Hematology Annual Meeting
05/03/2021 ISB 830 Telazorlimab in Atopic Dermatitis: Phase 2b Study Shows Improvement at 16 Weeks Sher, L. 2021 Society for Investigative Dermatology Virtual Meeting
01/28/2021 Cell Line Development Generation of homogeneous cell populations with tunable levels of transgene expression (PDF) Schlicht D. et al. Journal of Biotechnology
05/13/2020 BEAT® Antibody Engineering Platform A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species Stutz C. et al. Journal of Biological Chemistry
09/12/2019 BEAT® Antibody Engineering Platform Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development Ollier R. et al. mAbs

View Career Opportunities

Career Opportunities

The link above is provided for your convenience, and Ichnos is not responsible for content, privacy, or security issues associated with your visit to external websites.

Note: Assets that were previously identified as GBR XXXX are now identified as ISB XXXX.